Plasma protein binding evidence

Peptide

Measured material

Peptide backbone

Endpoint

ADMET domain

Distribution / Barrier

Value

Observation

Pramlintide does not extensively bind to blood cells or albumin (approximately 40% of the drug is unbound in plasma).

Evidence role

Reported: reviewed reported observation that should not be pooled as a comparable value yet

Assay / model

plasma protein

Condition

Route: SC · 19 · Pramlintide · exact product name match · exact or normalized match

Scientific source

PepTherDia

Developability